News
January 7, 2021
APL-106 (uproleselan) Granted Breakthrough Therapy Designation in China for the Treatment of Acute Myeloid Leukemia
Events
There are currently no upcoming events.
Partnering
Collaborations are vital to the success of our business.
To drive our proprietary programs forward, we have developed significant alliances with leading academics, governmental organizations and pharmaceutical/ biotechnology companies.
Learn More